1. The Transmodulation of HER2 and EGFR by Substance P in Breast Cancer Cells Requires c-Src and Metalloproteinase Activation
    Susana Garcia-Recio et al, 2015, PLOS ONE CrossRef
  2. Prognostic Significance of Substance P/Neurokinin 1 Receptor and Its Association with Hormonal Receptors in Breast Carcinoma
    Riffat Mehboob et al, 2021, BioMed Research International CrossRef
  3. Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis
    Emma Rodriguez et al, 2021, Cancers CrossRef
  4. Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-κB axis: Shedding new light on resistance to Aprepitant
    Davood Bashash et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
  5. Inhibition of tachykinin NK1 receptor using aprepitant induces apoptotic cell death and G1 arrest through Akt/p53 axis in pre-B acute lymphoblastic leukemia cells
    Samaneh Bayati et al, 2016, European Journal of Pharmacology CrossRef
  6. SP/NK‐1R promotes gallbladder cancer cell proliferation and migration
    Xue‐Ting Deng et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
  7. Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance
    Prema Robinson et al, 2016, BioMed Research International CrossRef
  8. Detection of neurokinin‐1 receptor by immunohistochemistry in canine mammary gland tumours
    Duri Song et al, 2020, Veterinary Medicine and Science CrossRef
  9. Radiochemical Synthesis and Evaluation of Novel Radioconjugates of Neurokinin 1 Receptor Antagonist Aprepitant Dedicated for NK1R-Positive Tumors
    Paweł K. Halik et al, 2020, Molecules CrossRef
  10. New insight into the role of substance P/neurokinin‐1 receptor system in breast cancer progression and its crosstalk with microRNAs
    Safieh Ebrahimi et al, 2020, Clinical Genetics CrossRef
  11. The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia
    Miguel Muñoz et al, 2020, Journal of Clinical Medicine CrossRef
  12. Activation of neuroimmune pathways increases therapeutic effects of radiotherapy on poorly differentiated breast carcinoma
    Nuray Erin et al, 2015, Brain, Behavior, and Immunity CrossRef
  13. The role of substance P/neurokinin 1 receptor in the pathogenesis of esophageal squamous cell carcinoma through constitutively active PI3K/Akt/NF-κB signal transduction pathways
    Hossein Javid et al, 2020, Molecular Biology Reports CrossRef
  14. Elevated Neurokinin-1 Receptor Expression in Uterine Products of Conception Is Associated With First Trimester Miscarriages
    Ahmad Alwazzan et al, 2020, Frontiers in Physiology CrossRef
  15. The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy
    Agnieszka Majkowska-Pilip et al, 2019, Pharmaceutics CrossRef
  16. Investigation of the Role of Neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF-κB Signal Transduction Pathways in Colon Cancer Cells
    Atefeh Ghahremanloo et al, 2021, BioMed Research International CrossRef
  17. The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs
    Miguel Muñoz et al, 2015, Journal of Biosciences CrossRef
  18. Targeting tachykinin receptors in neuroblastoma
    Anton G. Henssen et al, 2017, Oncotarget CrossRef
  19. Increased nuclear localization of substance P in human gastric tumor cells
    Miguel Muñoz et al, 2017, Acta Histochemica CrossRef
  20. The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer?
    Miguel Muñoz et al, 2020, Cancers CrossRef
  21. In Vivo, In Vitro and In Silico Studies of the Hybrid Compound AA3266, an Opioid Agonist/NK1R Antagonist with Selective Cytotoxicity
    Joanna Matalińska et al, 2020, International Journal of Molecular Sciences CrossRef
  22. Antileukemic effects of neurokinin-1 receptor inhibition on hematologic malignant cells
    Samaneh Bayati et al, 2018, Anti-Cancer Drugs CrossRef
  23. Neurokinin-1 Receptor Antagonists as Anticancer Drugs
    Miguel Muñoz et al, 2019, Letters in Drug Design & Discovery CrossRef
  24. Correlation of Clinicopathological Characteristics of Breast Carcinoma and Depression
    null Ilic et al, 2019, Healthcare CrossRef
  25. Immunolocalization of Substance P and NK‐1 Receptor in ADIPOSE Stem Cells
    Miguel Muñoz et al, 2017, Journal of Cellular Biochemistry CrossRef
  26. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in breast cancer
    Monireh Davoodian et al, 2019, Molecular Biology Reports CrossRef
  27. Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity
    Ashiq Legi et al, 2021, Cancers CrossRef
  28. The Neurokinins: Peptidomimetic Ligand Design and Therapeutic Applications
    Charlène Gadais et al, 2020, Current Medicinal Chemistry CrossRef
  29. Neurokinin-1 receptor mediated breast cancer cell migration by increased expression of MMP-2 and MMP-14
    Jingyi Li et al, 2016, European Journal of Cell Biology CrossRef
  30. Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells
    AGNÈS GARNIER et al, 2015, International Journal of Oncology CrossRef
  31. Triple Negative Breast Cancer: How Neurokinin-1 Receptor Antagonists Could Be Used as a New Therapeutic Approach
    Miguel Muñoz et al, 2020, Mini-Reviews in Medicinal Chemistry CrossRef
  32. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P
    Esra Nizam et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  33. Biological and Pharmacological Aspects of the NK1-Receptor
    Susana Garcia-Recio et al, 2015, BioMed Research International CrossRef
  34. The NK-1 receptor antagonist L-732,138 induces apoptosis in human gastrointestinal cancer cell lines
    Miguel Muñoz et al, 2017, Pharmacological Reports CrossRef
  35. Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload
    Chentao Ge et al, 2019, Proceedings of the National Academy of Sciences CrossRef